Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 753.06M | 699.02M | 635.67M | 627.87M | 592.25M |
Gross Profit | 103.48M | 96.80M | 75.12M | 110.44M | 119.64M |
EBITDA | 2.28M | 34.94M | -407.46M | -713.05M | 174.31M |
Net Income | -58.30M | -69.80M | -493.05M | -782.03M | -298.00K |
Balance Sheet | |||||
Total Assets | 958.12M | 1.00B | 1.08B | 1.56B | 2.61B |
Cash, Cash Equivalents and Short-Term Investments | 39.08M | 36.80M | 83.14M | 48.62M | 142.13M |
Total Debt | 766.37M | 750.18M | 797.70M | 852.00M | 1.31B |
Total Liabilities | 1.13B | 878.74M | 1.03B | 1.05B | 1.71B |
Stockholders Equity | -176.34M | 119.39M | 43.96M | 504.42M | 884.03M |
Cash Flow | |||||
Free Cash Flow | -34.02M | -29.69M | -93.66M | -84.07M | 116.47M |
Operating Cash Flow | -19.17M | -12.37M | -65.51M | -42.10M | 138.60M |
Investing Cash Flow | -14.25M | -17.37M | -28.05M | -39.89M | -21.81M |
Financing Cash Flow | 35.70M | -16.61M | 128.08M | -11.52M | -12.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $1.25B | 37.80 | 6.72% | 2.19% | 14.30% | 76.89% | |
56 Neutral | $178.89M | ― | -27.25% | ― | -26.14% | 23.04% | |
52 Neutral | $7.50B | 0.31 | -61.87% | 2.27% | 17.10% | 1.59% | |
49 Neutral | $839.20M | 18.62 | -21.08% | ― | -18.13% | -215.78% | |
49 Neutral | $46.65M | ― | -951.52% | ― | -0.70% | -2.38% | |
44 Neutral | $4.37M | ― | -61.61% | ― | 7.73% | 36.23% | |
39 Underperform | $25.18M | ― | 14.03% | ― | -29.82% | -2.57% |
On March 3, 2025, ATI Physical Therapy closed a $26 million second lien PIK convertible note financing, maturing in 2028 with an 8% interest rate. This financing aims to strengthen ATI’s financial foundation and support its strategic vision, while significant stockholders hold substantial voting power, potentially facilitating a short-form merger.